180 related articles for article (PubMed ID: 16582616)
21. The SWI/SNF complex--chromatin and cancer.
Roberts CW; Orkin SH
Nat Rev Cancer; 2004 Feb; 4(2):133-42. PubMed ID: 14964309
[No Abstract] [Full Text] [Related]
22. Increased DNA damage sensitivity and apoptosis in cells lacking the Snf5/Ini1 subunit of the SWI/SNF chromatin remodeling complex.
Klochendler-Yeivin A; Picarsky E; Yaniv M
Mol Cell Biol; 2006 Apr; 26(7):2661-74. PubMed ID: 16537910
[TBL] [Abstract][Full Text] [Related]
23. [Chromatin remodeling defects and cancer: the SWI/SNF example].
Bourdeaut F; Bièche I
Bull Cancer; 2012 Dec; 99(12):1133-40. PubMed ID: 23222069
[TBL] [Abstract][Full Text] [Related]
24. Fibroblast growth factor receptors as novel therapeutic targets in SNF5-deleted malignant rhabdoid tumors.
Wöhrle S; Weiss A; Ito M; Kauffmann A; Murakami M; Jagani Z; Thuery A; Bauer-Probst B; Reimann F; Stamm C; Pornon A; Romanet V; Guagnano V; Brümmendorf T; Sellers WR; Hofmann F; Roberts CW; Graus Porta D
PLoS One; 2013; 8(10):e77652. PubMed ID: 24204904
[TBL] [Abstract][Full Text] [Related]
25. SWI/SNF nucleosome remodellers and cancer.
Wilson BG; Roberts CW
Nat Rev Cancer; 2011 Jun; 11(7):481-92. PubMed ID: 21654818
[TBL] [Abstract][Full Text] [Related]
26. The SWI/SNF tumor suppressor complex: Regulation of promoter nucleosomes and beyond.
Lu P; Roberts CW
Nucleus; 2013; 4(5):374-8. PubMed ID: 24145903
[TBL] [Abstract][Full Text] [Related]
27. The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression.
Klochendler-Yeivin A; Fiette L; Barra J; Muchardt C; Babinet C; Yaniv M
EMBO Rep; 2000 Dec; 1(6):500-6. PubMed ID: 11263494
[TBL] [Abstract][Full Text] [Related]
28. Cellular senescence regulated by SWI/SNF complex subunits through p53/p21 and p16/pRB pathway.
He L; Chen Y; Feng J; Sun W; Li S; Ou M; Tang L
Int J Biochem Cell Biol; 2017 Sep; 90():29-37. PubMed ID: 28716547
[TBL] [Abstract][Full Text] [Related]
29. SWI/SNF chromatin remodeling and human malignancies.
Masliah-Planchon J; Bièche I; Guinebretière JM; Bourdeaut F; Delattre O
Annu Rev Pathol; 2015; 10():145-71. PubMed ID: 25387058
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation.
Wilson BG; Wang X; Shen X; McKenna ES; Lemieux ME; Cho YJ; Koellhoffer EC; Pomeroy SL; Orkin SH; Roberts CW
Cancer Cell; 2010 Oct; 18(4):316-28. PubMed ID: 20951942
[TBL] [Abstract][Full Text] [Related]
31. Recurrent SMARCB1 Mutations Reveal a Nucleosome Acidic Patch Interaction Site That Potentiates mSWI/SNF Complex Chromatin Remodeling.
Valencia AM; Collings CK; Dao HT; St Pierre R; Cheng YC; Huang J; Sun ZY; Seo HS; Mashtalir N; Comstock DE; Bolonduro O; Vangos NE; Yeoh ZC; Dornon MK; Hermawan C; Barrett L; Dhe-Paganon S; Woolf CJ; Muir TW; Kadoch C
Cell; 2019 Nov; 179(6):1342-1356.e23. PubMed ID: 31759698
[TBL] [Abstract][Full Text] [Related]
32. The SWI/SNF chromatin-remodeling complex subunit SNF5 is essential for hepatocyte differentiation.
Gresh L; Bourachot B; Reimann A; Guigas B; Fiette L; Garbay S; Muchardt C; Hue L; Pontoglio M; Yaniv M; Klochendler-Yeivin A
EMBO J; 2005 Sep; 24(18):3313-24. PubMed ID: 16138077
[TBL] [Abstract][Full Text] [Related]
33. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV
Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802
[TBL] [Abstract][Full Text] [Related]
34. Chromatin regulators with tumor suppressor properties and their alterations in human cancers.
Shu XS; Li L; Tao Q
Epigenomics; 2012 Oct; 4(5):537-49. PubMed ID: 23130835
[TBL] [Abstract][Full Text] [Related]
35. Use of clinical next-generation sequencing to identify melanomas harboring SMARCB1 mutations.
Stockman DL; Curry JL; Torres-Cabala CA; Watson IR; Siroy AE; Bassett RL; Zou L; Patel KP; Luthra R; Davies MA; Wargo JA; Routbort MA; Broaddus RR; Prieto VG; Lazar AJ; Tetzlaff MT
J Cutan Pathol; 2015 May; 42(5):308-17. PubMed ID: 25754356
[TBL] [Abstract][Full Text] [Related]
36. BAFfling pathologies: Alterations of BAF complexes in cancer.
Arnaud O; Le Loarer F; Tirode F
Cancer Lett; 2018 Apr; 419():266-279. PubMed ID: 29374542
[TBL] [Abstract][Full Text] [Related]
37. The role of the SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma.
Tsuda M; Fukuda A; Kawai M; Araki O; Seno H
Cancer Sci; 2021 Feb; 112(2):490-497. PubMed ID: 33301642
[TBL] [Abstract][Full Text] [Related]
38. The SWI/SNF complex and cancer.
Reisman D; Glaros S; Thompson EA
Oncogene; 2009 Apr; 28(14):1653-68. PubMed ID: 19234488
[TBL] [Abstract][Full Text] [Related]
39. Molecular pathways: SWI/SNF (BAF) complexes are frequently mutated in cancer--mechanisms and potential therapeutic insights.
Wang X; Haswell JR; Roberts CW
Clin Cancer Res; 2014 Jan; 20(1):21-7. PubMed ID: 24122795
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of MYC by the SMARCB1 tumor suppressor.
Weissmiller AM; Wang J; Lorey SL; Howard GC; Martinez E; Liu Q; Tansey WP
Nat Commun; 2019 May; 10(1):2014. PubMed ID: 31043611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
